Hydroxychloroquine placebo trial

1016/j. Authors Feb 1, 2021 · Design, setting, and participants: This randomized, double-blind, placebo-controlled clinical trial (the Prevention and Treatment of COVID-19 With Hydroxychloroquine Study) was conducted at 2 tertiary urban hospitals, with enrollment from April 9, 2020, to July 14, 2020; follow-up ended August 4, 2020

2024-03-28
    Allopurinol purinase side effects
  1. The control group will receive equivalent numbers of placebo pills
  2. Epub 2020 Nov 20
  3. 2022
  4. If hydroxychloroquine ranks better than placebo (i
  5. 6 to 3
  6. , Walmsley, S
  7. 2014; 73 (Suppl 2):756-757
  8. The median patient age was 57
  9. Keywords: Coronavirus disease
  10. EClinicalMedicine
  11. The StopRA study, a double-blind
  12. This document prov
  13. gov: NCT04308668)